Method and composition for ameliorating the adverse effects of aging
CA 2108369 C · Owner: Senetek, Plc · Inventors: Rattan, Suresh I. S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
6-(substituted amino)purine cytokinins including kinetin, have been , discovered to ameliorate the adverse effects of aging on mammalian cells, by slowing or reversing the morphological changes that normally accompany aging of such cells without, significantly increasing the growth rate or total proliferative capacity of such cells. Thus, method are provided for countering the adverse effects of aging on cells in culture and in vivo which comprise administering to said cells an adverse-age-effect-ameliorative amount of kinetin or, another 6-(substituted amino)purine cytokinin. Compositions for carrying out the methods are also provided. Among the preferred applications of the invention …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 16, 1991 and granted January 28, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 16, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 16, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.